Japan Embarks On Rx-To-OTC Switch Revolution
Executive Summary
The Japanese government has approved a raft of measures aimed at expanding the country's consumer health market, including reforms to an Evaluation Committee that has not lived up to its promise of expediting Rx-to-OTC switches.
You may also be interested in...
Japan’s Switch Committee Resists Full Reform
Japan’s Rx-to-OTC Switching Evaluation Committee has accepted most of the reforms mandated by the country’s government as part of its attempt to reform the national medicines reclassification system. However, it still has more of a role than industry would perhaps like.
Takeda Exits Japan's OTC Market With Private-Equity Sale
Takeda is to offload its sizable Japanese OTC operation to private-equity firm Blackstone, which has committed to making the business the country's leading consumer health player.
Asia’s OTC Market Stunted By Regulatory Disharmony
HBW Insight Exclusive: A lack of regulatory harmonization, especially with regards to Rx-to-OTC switch, is holding the Asia-Pacific OTC market back, according to APSMI secretary general, Toshi Tominaga.